Transient ischemic attack--proposal for a new definition.

PubWeight™: 4.94‹?› | Rank: Top 1%

🔗 View Article (PMID 12444191)

Published in N Engl J Med on November 21, 2002

Authors

Gregory W Albers1, Louis R Caplan, J Donald Easton, Pierre B Fayad, J P Mohr, Jeffrey L Saver, David G Sherman, TIA Working Group

Author Affiliations

1: Stanford University School of Medicine Palo Alto, CA 94305, USA.

Associated clinical trials:

Essential Hypotension and Adaptability Registry (EssentialHAR) | NCT02018497

Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score | NCT00553241

Task-oriented Progressive Resistance Strength Training and Balance Exercises on Lower Limb in Individuals With Stroke | NCT04820660

Articles citing this

Measuring diagnoses: ICD code accuracy. Health Serv Res (2005) 6.72

Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62

Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55

Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol (2014) 1.72

Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry (2005) 1.58

Management and outcomes of transient ischemic attacks in Ontario. CMAJ (2004) 1.27

Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol (2005) 1.26

Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res (2008) 1.25

Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ (2004) 1.22

Carotid artery calcification on CT may independently predict stroke risk. AJR Am J Roentgenol (2006) 1.14

Imaging of acute stroke. Nat Rev Neurol (2010) 1.09

Validation and refinement of the ABCD2 score: a population-based analysis. Stroke (2009) 1.04

Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims. Circ Cardiovasc Qual Outcomes (2014) 1.03

Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation. Biochim Biophys Acta (2010) 1.02

White matter hyperintensity burden and susceptibility to cerebral ischemia. Stroke (2010) 0.97

Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam Study. J Neurol (2007) 0.97

Killer proteases and little strokes--how the things that do not kill you make you stronger. J Cereb Blood Flow Metab (2006) 0.96

Diffusion-weighted MR imaging in transient ischaemic attacks. Eur Radiol (2006) 0.94

Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial. BMC Neurol (2010) 0.94

Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med (2009) 0.92

Transient ischemic attacks. N Engl J Med (2002) 0.90

Brain imaging in patients with transient ischemic attack: a comparison of computed tomography and magnetic resonance imaging. Eur Neurol (2012) 0.87

Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke (2007) 0.87

The impact of expansive arterial remodeling on clinical presentation in carotid artery disease: a multidetector CT angiography study. AJNR Am J Neuroradiol (2007) 0.86

The incidence and clinical predictors of acute infarction in patients with transient ischemic attack using MRI including DWI. Neuroradiology (2012) 0.86

Aberrant functional connectivity of resting state networks in transient ischemic attack. PLoS One (2013) 0.86

A Q-Methodology Study of Patients' Subjective Experiences of TIA. Stroke Res Treat (2012) 0.85

Accuracy of Electronic Health Record Data for Identifying Stroke Cases in Large-Scale Epidemiological Studies: A Systematic Review from the UK Biobank Stroke Outcomes Group. PLoS One (2015) 0.84

Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol (2007) 0.84

The patient with transient cerebral ischemia: a golden opportunity for stroke prevention. CMAJ (2004) 0.84

Reliability, validity, and optimal cutoff score of the montreal cognitive assessment (changsha version) in ischemic cerebrovascular disease patients of hunan province, china. Dement Geriatr Cogn Dis Extra (2013) 0.84

Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke. Arterioscler Thromb Vasc Biol (2016) 0.81

Management of carotid artery stenosis. Update for family physicians. Can Fam Physician (2005) 0.81

Periodontal disease and recurrent vascular events in stroke/transient ischemic attack patients. J Stroke Cerebrovasc Dis (2013) 0.81

Transient ischemic attack--proposed new definition. N Engl J Med (2003) 0.81

Posterior circulation stroke: animal models and mechanism of disease. J Biomed Biotechnol (2012) 0.81

Plaque vulnerability in internal carotid arteries with positive remodeling. Cerebrovasc Dis Extra (2011) 0.81

Accuracy of identifying acute stroke admissions in a Michigan Stroke Registry. Prev Chronic Dis (2011) 0.80

Acute stroke diagnosis. Am Fam Physician (2009) 0.80

Protection of ischemic postconditioning against neuronal apoptosis induced by transient focal ischemia is associated with attenuation of NF-κB/p65 activation. PLoS One (2014) 0.80

Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ (2015) 0.80

Large-artery stenosis predicts subsequent vascular events in patients with transient ischemic attack. J Clin Neurol (2007) 0.80

A retrospective cohort study to investigate fatigue, psychological or cognitive impairment after TIA: protocol paper. BMJ Open (2015) 0.79

A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra (2013) 0.79

Transient ischaemic attack (TIA) knowledge in general practice: a cross-sectional study of Western Adelaide general practitioners. BMC Res Notes (2012) 0.79

Delay in seeking medical help following Transient Ischemic Attack (TIA) or "mini-stroke": a qualitative study. PLoS One (2014) 0.79

Temporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patients. Mol Med Rep (2016) 0.78

Neurological signs in 23 dogs with suspected rostral cerebellar ischaemic stroke. Acta Vet Scand (2016) 0.78

Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study. Cardiovasc Diabetol (2015) 0.78

Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group. PLoS One (2015) 0.78

How much would performing diffusion-weighted imaging for all transient ischemic attacks increase MRI utilization? Stroke (2010) 0.78

Neurological disorders in essential thrombocythemia. Haematologica (2011) 0.78

A systematic review investigating fatigue, psychological and cognitive impairment following TIA and minor stroke: protocol paper. Syst Rev (2013) 0.77

Neuroprotective effects of erythropoietin in acute ischemic stroke. Int J Prev Med (2013) 0.77

Hyperhomocysteinemia is Associated with Aortic Atheroma Progression in Stroke/TIA Patients. Front Neurol (2010) 0.76

Risk factors of transient ischemic attack: An overview. J Midlife Health (2016) 0.76

Association of Rs2071410 on Furin with Transient Ischemic Attack Susceptibility and Prognosis in a Chinese Population. Med Sci Monit (2016) 0.76

Transient ischemic attack presenting in an elderly patient with transient ophthalmic manifestations. Oman J Ophthalmol (2016) 0.75

Transient ischemic attack--proposed new definition. N Engl J Med (2003) 0.75

Magnetic resonance imaging in patients with transient ischemic attack. Neural Regen Res (2014) 0.75

Transient ischemic attack--proposed new definition. N Engl J Med (2003) 0.75

Management, prognosis and predictors of unfavourable outcomes in patients newly hospitalized for transient ischemic attack: a real-world investigation from Italy. BMC Neurol (2017) 0.75

A randomized controlled trial to assess the central hemodynamic response to exercise in patients with transient ischaemic attack and minor stroke. J Hum Hypertens (2016) 0.75

Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements. AAPS PharmSciTech (2015) 0.75

Short-Term Prognosis of Transient Ischemic Attack and Predictive Value of the ABCD(2) Score in Hong Kong Chinese. Cerebrovasc Dis Extra (2014) 0.75

Control of cerebral ischemia with magnetic nanoparticles. Nat Methods (2016) 0.75

Referral pathways for patients with TIA avoiding hospital admission: a scoping review. BMJ Open (2017) 0.75

Juxtacortical spots on fluid-attenuated inversion recovery images in cryptogenic transient ischemic attack. J Clin Neurol (2013) 0.75

Trends in Transient Ischemic Attack Hospitalizations in the United States. J Am Heart Assoc (2016) 0.75

Ischemic stroke in infants and children: practical management in emergency. Stroke Res Treat (2011) 0.75

Epidemiology of non-fatal cerebrovascular stroke and transient ischemic attacks in Al Quseir, Egypt. Clin Interv Aging (2013) 0.75

Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc (2016) 0.75

Role of Diffusion-weighted Imaging in Acute Stroke Management using Low-field Magnetic Resonance Imaging in Resource-limited Settings. West Afr J Radiol (2015) 0.75

Multiparametric Approach Enhances Detection of Patients with Cerebral TIAs at Risk of Stroke: A Prospective Pilot Case Series. J Vasc Interv Neurol (2016) 0.75

Frequency of emerging positive diffusion-weighted imaging in early repeat examinations at least 24 h after transient ischemic attacks. Neuroradiology (2012) 0.75

Transient ischemic attack-like episodes without stroke-like lesions in MELAS. Pediatr Radiol (2013) 0.75

Articles by these authors

Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 14.49

A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97

The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke (2009) 6.62

Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke (2009) 5.91

Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72

Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Morning increase in onset of ischemic stroke. Stroke (1989) 3.52

Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52

Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2010) 3.51

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51

Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46

Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30

The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19

Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13

The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12

Diagnosis of acute neurological emergencies in pregnant and post-partum women. Lancet Neurol (2013) 2.98

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82

Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76

MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75

Dizziness: how do patients describe dizziness and how do emergency physicians use these descriptions for diagnosis? Mayo Clin Proc (2007) 2.75

Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66

Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62

An uncommon cause of intracerebral hemorrhage in a healthy truck driver. Arch Neurol (2012) 2.61

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56

CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50

Broca aphasia: pathologic and clinical. Neurology (1978) 2.43

Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42

Medical complications after stroke. Lancet Neurol (2010) 2.42

The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42

Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38

The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31

Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31

Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol (2004) 2.30

Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28

Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23

Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21

Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20

Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke (2011) 2.19

Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17

Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15

The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14

Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke (2006) 2.09

Vertebrobasilar disease. N Engl J Med (2005) 2.06

Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06

Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05

Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04

Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03

Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02

Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02

Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97

Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke (2009) 1.96

Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke (2007) 1.94

Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke (2002) 1.93

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke (2011) 1.92

Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92

Behavioral studies of aphasia: methods of investigation and analysis. Neuropsychologia (1971) 1.92

Pitfalls in the diagnosis of cerebellar infarction. Acad Emerg Med (2007) 1.87

A midlife stroke surge among women in the United States. Neurology (2007) 1.86

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet (2012) 1.83

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J (2010) 1.82

Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology (2003) 1.81

Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke (2000) 1.79

Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study. Neurology (2006) 1.78

Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology (1992) 1.78

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol (2005) 1.77

Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76

Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75

The epidemiology of brain arteriovenous malformations. Neurosurgery (2000) 1.75

Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke (2007) 1.75

Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke (1998) 1.75

Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet (1997) 1.73

Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73

Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke (2009) 1.72

Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71

Distinct syndromes of hemineglect. Arch Neurol (1992) 1.71

'Steal' is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke (1995) 1.70

Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol (2005) 1.69

Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68

Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67